# A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea

> **NCT07379840** · — · RECRUITING · sponsor: **Bayer** · enrollment: 300 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** finerenone (BAY94-8862)

## Key facts

- **NCT ID:** NCT07379840
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-23
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379840, "A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07379840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*